# Medical & Research

Episodes of The Dime Podcast covering Medical & Research: cannabis business conversations with founders, executives and investors. 33 episodes.

- Canonical: https://www.dimepodcast.com/topics/medical-and-research
- Topic index for agents: https://www.dimepodcast.com/topics/medical-and-research/llms.txt
- All topics: https://www.dimepodcast.com/topics

## Analysis on Medical & Research

First Principles essays by Bryan Fields. Human written.

- [The Cannabis Industry Fought for Medical Access. Why Is It Silent Now?](https://www.dimepodcast.com/newsletter/the-cannabis-industry-fought-for-medical-access-why-is-it-silent-now) (August 4, 2026): The federal hemp ban arrives in November. It was aimed at intoxicating products, but the language is broad enough to take therapeutic CBD with it.
  Markdown: https://www.dimepodcast.com/newsletter/the-cannabis-industry-fought-for-medical-access-why-is-it-silent-now.md
- [The Cannabis Medical Thesis Was Never Wrong. The World Just Forgot.](https://www.dimepodcast.com/newsletter/the-cannabis-medical-thesis-was-never-wrong-the-world-just-forgot) (May 27, 2026): Cannabis started as a medical story, then the green rush buried it. The FDA's botanical drug pathway is what brings the original thesis back.
  Markdown: https://www.dimepodcast.com/newsletter/the-cannabis-medical-thesis-was-never-wrong-the-world-just-forgot.md
- [Before CBD Was a Category, It Was a Medical Necessity](https://www.dimepodcast.com/newsletter/before-cbd-was-a-category-it-was-a-medical-necessity) (January 13, 2026): CBD didn't earn acceptance through branding. It earned it because results showed up where nothing else worked — and Schedule III raises the bar again.
  Markdown: https://www.dimepodcast.com/newsletter/before-cbd-was-a-category-it-was-a-medical-necessity.md
- [CBD: The Gateway Cannabinoid](https://www.dimepodcast.com/newsletter/cbd-the-gateway-cannabinoid) (December 22, 2025): Schedule III put CBD first for a reason: it's the lowest-friction entry point for FDA oversight. The agency will apply the playbook it knows.
  Markdown: https://www.dimepodcast.com/newsletter/cbd-the-gateway-cannabinoid.md
- [Why Some Cannabis Research Can't Be Trusted](https://www.dimepodcast.com/newsletter/why-some-cannabis-research-cant-be-trusted) (September 25, 2025): When billions are on the line, research gets messy. Read closely, stay skeptical — and know which meta-analysis actually put the numbers on the table.
  Markdown: https://www.dimepodcast.com/newsletter/why-some-cannabis-research-cant-be-trusted.md
- [THC Is Just an Ingredient — How Schedule III Will Reshape Cannabis, Pharma & Hemp](https://www.dimepodcast.com/newsletter/thc-is-just-an-ingredient-how-schedule-iii-will-reshape-cannabis-pharma-and-hemp) (September 15, 2025): What if cannabis operators had to buy cannabinoids from GMP-licensed manufacturers instead of retrofitting facilities? The supply chain flips overnight.
  Markdown: https://www.dimepodcast.com/newsletter/thc-is-just-an-ingredient-how-schedule-iii-will-reshape-cannabis-pharma-and-hemp.md
- [Beyond THC%: Unlocking Cannabis' True Language with Sensory Science](https://www.dimepodcast.com/newsletter/beyond-thc-unlocking-cannabis-true-language-with-sensory-science) (September 5, 2025): Nobody buys wine by ABV. THC% is pushing cannabis toward commodity, and sensory science backed by data is the missing lexicon.
  Markdown: https://www.dimepodcast.com/newsletter/beyond-thc-unlocking-cannabis-true-language-with-sensory-science.md

## Episodes

- [Paige Figi: The Cannabis Industry Is Cheering A Ban On Medicine](https://www.dimepodcast.com/episodes/paige-figi-the-cannabis-industry-is-cheering-a-ban-on-medicine) — Paige Figi: In this episode, Paige Figi — mother of Charlotte Figi, whose story helped launch the modern medical CBD movement — breaks down the looming November 12th federal ban on hemp-derived CBD products and…
  Markdown: https://www.dimepodcast.com/episodes/paige-figi-the-cannabis-industry-is-cheering-a-ban-on-medicine.md
- [Hirsh Jain: Rescheduling Is Already Picking Winners](https://www.dimepodcast.com/episodes/hirsh-jain-rescheduling-is-already-picking-winners) — Hirsh Jain: This episode features cannabis strategist Hirsh Jain unpacking the confusing reality behind the April 2025 rescheduling order — explaining why medical cannabis moved to Schedule III while adult-use…
  Markdown: https://www.dimepodcast.com/episodes/hirsh-jain-rescheduling-is-already-picking-winners.md
- [Cannabis Was Medicine. Now the Proof Is Catching Up, ft. Joel Stanley and Dr. Marcel Bonn-Miller](https://www.dimepodcast.com/episodes/cannabis-was-medicine-now-the-proof-is-catching-up-ft-joel-stanley-and-dr-marcel-bonn-miller) — Joel Stanley and Dr. Marcel Bonn-Miller: This episode features Joel Stanley, founding CEO of Charlotte's Web and now founder of Ozna Biosciences, and Dr. Marcel Bonn-Miller, a longtime cannabinoid researcher, discussing why proving cannabis…
  Markdown: https://www.dimepodcast.com/episodes/cannabis-was-medicine-now-the-proof-is-catching-up-ft-joel-stanley-and-dr-marcel-bonn-miller.md
- [How Charlotte’s Web Unlocked Medical CBD ft. Bill Morachnick](https://www.dimepodcast.com/episodes/how-charlottes-web-unlocked-medical-cbd-ft-bill-morachnick) — Bill Morachnick: Charlotte's Web CEO Bill Morachnick joins The Dime to tell the origin story behind Charlotte Figi and the company's namesake, and to unpack a newly signed executive order that opens the door to…
  Markdown: https://www.dimepodcast.com/episodes/how-charlottes-web-unlocked-medical-cbd-ft-bill-morachnick.md
- [Schedule III Changes Everything — This Is Just the Beginning](https://www.dimepodcast.com/episodes/schedule-iii-changes-everything-this-is-just-the-beginning) — Guest: This emergency episode of The Dime breaks down the same-day executive order moving cannabis toward Schedule III, featuring cannabinoid manufacturing experts Zach Edge and Matthew Moore of RHO…
  Markdown: https://www.dimepodcast.com/episodes/schedule-iii-changes-everything-this-is-just-the-beginning.md
- [How LEVEL Delivers Effects-Based Cannabis Tablets ft. Chris Emerson](https://www.dimepodcast.com/episodes/how-level-delivers-effects-based-cannabis-tablets-ft-chris-emerson) — Chris Emerson: In this episode of The Dime, Bryan Fields and Kellan Finney talk with Chris Emerson, founder of Level, about building an effects-based cannabinoid tablet company grounded in his PhD chemistry…
  Markdown: https://www.dimepodcast.com/episodes/how-level-delivers-effects-based-cannabis-tablets-ft-chris-emerson.md
- [Largest Medical Cannabis & Cancer Study Ever: Can These Findings Push Rescheduling? ft Ryan Castle](https://www.dimepodcast.com/episodes/largest-medical-cannabis-cancer-study-ever-can-these-findings-push-rescheduling-ft-ryan-castle) — Ryan Castle: This episode of The Dime features Ryan Castle, research director at Whole Health Oncology Institute, discussing the largest medical cannabis and cancer meta-analysis ever conducted — spanning over…
  Markdown: https://www.dimepodcast.com/episodes/largest-medical-cannabis-cancer-study-ever-can-these-findings-push-rescheduling-ft-ryan-castle.md
- [Sensory Science Unlocked, Beyond THC, Inside True Terpenes ft. Dan Cook](https://www.dimepodcast.com/episodes/sensory-science-unlocked-beyond-thc-inside-true-terpenes-ft-dan-cook) — Dan Cook: This episode of The Dime features Dan Cook, CEO of True Terpenes, discussing why THC percentage is a flawed proxy for cannabis quality and how sensory science — the full spectrum of terpenes, esters,…
  Markdown: https://www.dimepodcast.com/episodes/sensory-science-unlocked-beyond-thc-inside-true-terpenes-ft-dan-cook.md
- [Dr. Greenhouse: The #1 Mistake Killing Your Plants ft. Nadia Sabeh](https://www.dimepodcast.com/episodes/dr-greenhouse-the-1-mistake-killing-your-plants-ft-nadia-sabeh) — Nadia Sabeh: This episode of The Dime features Nadia Sabeh, founder of climate-control engineering firm Dr. Greenhouse, breaking down why HVAC and environmental mismanagement is one of the most common — and…
  Markdown: https://www.dimepodcast.com/episodes/dr-greenhouse-the-1-mistake-killing-your-plants-ft-nadia-sabeh.md
- [The Michelin-Star Experience? Gibran Washington on What Customers Actually Want](https://www.dimepodcast.com/episodes/the-michelin-star-experience-gibran-washington-on-what-customers-actually-want) — Gibran Washington: Gibran Washington, CEO of Ethos Cannabis, joins The Dime to explain why his company built the first cannabis clinical research partnership with a major medical institution — Thomas Jefferson…
  Markdown: https://www.dimepodcast.com/episodes/the-michelin-star-experience-gibran-washington-on-what-customers-actually-want.md
- [How Leafwell is Disrupting Healthcare: The Data Doctors Can’t Ignore ft. Emily Fisher & Dr June Chin](https://www.dimepodcast.com/episodes/how-leafwell-is-disrupting-healthcare-the-data-doctors-cant-ignore-ft-emily-fisher-dr-june-chin) — Emily Fisher & Dr June Chin: Leafwell co-founder Emily Fisher and Dr. June Chin, a physician and vice chair of New York State's cannabis advisory board, explain how their telehealth platform has grown into a data-driven cannabis…
  Markdown: https://www.dimepodcast.com/episodes/how-leafwell-is-disrupting-healthcare-the-data-doctors-cant-ignore-ft-emily-fisher-dr-june-chin.md
- [Stop Ignoring Germany’s Massive Opportunity – Europe is Coming! ft. Jamie Pearson](https://www.dimepodcast.com/episodes/stop-ignoring-germanys-massive-opportunity-europe-is-coming-ft-jamie-pearson) — Jamie Pearson: In this episode of The Dime, hosts Bryan Fields and Kellan sit down with Jamie Pearson, president of New Holland Group and former CEO of Bhang, to unpack Germany's fast-evolving cannabis landscape…
  Markdown: https://www.dimepodcast.com/episodes/stop-ignoring-germanys-massive-opportunity-europe-is-coming-ft-jamie-pearson.md
- [Uniform Genetics, F1 Hybrids, Better Yields: New Age Cannabis Cultivation ft. Ralph Risch](https://www.dimepodcast.com/episodes/uniform-genetics-f1-hybrids-better-yields-new-age-cannabis-cultivation-ft-ralph-risch) — Ralph Risch: This episode of The Dime features Ralph Risch, CEO of Phylos Bioscience, discussing how genomic-driven, science-based breeding is transforming cannabis cultivation through F1 hybrid seeds. Risch…
  Markdown: https://www.dimepodcast.com/episodes/uniform-genetics-f1-hybrids-better-yields-new-age-cannabis-cultivation-ft-ralph-risch.md
- [Inside Curio Wellness with Wendy Bronfein: Maryland vs. Missouri Cannabis Markets and Crohn’s Treatment](https://www.dimepodcast.com/episodes/inside-curio-wellness-with-wendy-bronfein-maryland-vs-missouri-cannabis-markets-and-crohns-treatment) — Wendy Bronfein: In this episode of The Dime, Curio Wellness co-founder Wendy Bronfein joins hosts Bryan Fields and Kellan Finney to trace her path from Baltimore television to launching one of Maryland's first…
  Markdown: https://www.dimepodcast.com/episodes/inside-curio-wellness-with-wendy-bronfein-maryland-vs-missouri-cannabis-markets-and-crohns-treatment.md
- [Post-Harvest Cultivation Secrets to Maximize Terpenes ft. Jack Grover](https://www.dimepodcast.com/episodes/post-harvest-cultivation-secrets-to-maximize-terpenes-ft-jack-grover) — Jack Grover: This episode of The Dime features Jack Grover, co-founder of Grove Bags, discussing the science and business of post-harvest cannabis cultivation, curing, and packaging. Grover explains how moisture…
  Markdown: https://www.dimepodcast.com/episodes/post-harvest-cultivation-secrets-to-maximize-terpenes-ft-jack-grover.md
- [What is Tissue Culture, Genetic Resets and Breeder Rights Explained ft. Kristian Andreassen](https://www.dimepodcast.com/episodes/what-is-tissue-culture-genetic-resets-and-breeder-rights-explained-ft-kristian-andreassen) — Kristian Andreassen: This episode of The Dime features Kristian Andreassen of Conception Nurseries, California's only gen-zero tissue culture cannabis nursery, breaking down what tissue culture actually is and why it…
  Markdown: https://www.dimepodcast.com/episodes/what-is-tissue-culture-genetic-resets-and-breeder-rights-explained-ft-kristian-andreassen.md
- [How U.S. Cannabis Legalization Will Shape Global Influence ft. Hirsh Jain](https://www.dimepodcast.com/episodes/how-us-cannabis-legalization-will-shape-global-influence-ft-hirsh-jain) — Hirsh Jain: This episode of The Dime features Hirsh Jain, founder of Anunda Strategy, discussing how U.S. cannabis legalization could shape global drug policy and geopolitical soft power, drawing parallels to…
  Markdown: https://www.dimepodcast.com/episodes/how-us-cannabis-legalization-will-shape-global-influence-ft-hirsh-jain.md
- [Kanha Edibles on a Thai Beach: Global Strategy & Personalized Cannabinoid Therapy with Cameron Clarke](https://www.dimepodcast.com/episodes/kanha-edibles-on-a-thai-beach-global-strategy-personalized-cannabinoid-therapy-with-cameron-clarke) — Cameron Clarke: This episode of The Dime features Cameron Clarke, CEO of edibles brand Kanha, tracing the company's origin from a backyard algae-extraction experiment to becoming one of the largest gummy and…
  Markdown: https://www.dimepodcast.com/episodes/kanha-edibles-on-a-thai-beach-global-strategy-personalized-cannabinoid-therapy-with-cameron-clarke.md
- [Surprising Medical Uses of Cannabis: First-Hand Insights from Dr. Benjamin Caplan on Cancer, Dementia, and Skincare](https://www.dimepodcast.com/episodes/surprising-medical-uses-of-cannabis-first-hand-insights-from-dr-benjamin-caplan-on-cancer-dementia-and-skincare) — Dr. Benjamin Caplan: In this episode of The Dime, hosts Bryan Fields and Kellan Finney speak with Dr. Benjamin Caplan, a Boston-based primary care physician, founder of Seed Clinic, and author of the Doctor-Approved…
  Markdown: https://www.dimepodcast.com/episodes/surprising-medical-uses-of-cannabis-first-hand-insights-from-dr-benjamin-caplan-on-cancer-dementia-and-skincare.md
- [Emily Sisneros: Kentucky's Hot Medical Market and Winning Cannabis Licenses](https://www.dimepodcast.com/episodes/emily-sisneros-kentuckys-hot-medical-market-and-winning-cannabis-licenses) — Emily Sisneros: In this episode of The Dime, hosts Bryan Fields and Kellan Finney talk with Emily Sisneros, a cannabis licensing attorney-turned-consultant and CEO of Canna Business Services, about her path from…
  Markdown: https://www.dimepodcast.com/episodes/emily-sisneros-kentuckys-hot-medical-market-and-winning-cannabis-licenses.md
- [Can CBN Replace Melatonin? Results from a Double-Blind Placebo-Controlled Study ft. Alleh Lindquist](https://www.dimepodcast.com/episodes/can-cbn-replace-melatonin-results-from-a-double-blind-placebo-controlled-study-ft-alleh-lindquist) — Alleh Lindquist: This episode of The Dime features Alleh Lindquist, CEO of FlorWorks, discussing how his company built a proprietary, patented CBN compound ("True CBN") and ran a large double-blind,…
  Markdown: https://www.dimepodcast.com/episodes/can-cbn-replace-melatonin-results-from-a-double-blind-placebo-controlled-study-ft-alleh-lindquist.md
- [How Minor Cannabinoids are Made: Synthetic vs Biosynthetic ft. Shane Johnson](https://www.dimepodcast.com/episodes/how-minor-cannabinoids-are-made-synthetic-vs-biosynthetic-ft-shane-johnson) — Shane Johnson: This episode of The Dime features Shane Johnson, SVP and GM of BayMedica (a subsidiary of InMed Pharmaceuticals), explaining how minor and rare cannabinoids like CBC, CBN, and THCV are produced…
  Markdown: https://www.dimepodcast.com/episodes/how-minor-cannabinoids-are-made-synthetic-vs-biosynthetic-ft-shane-johnson.md
- [Unveiling the $4 Million Problem: Hop Latent Viroid's Impact on Cannabis Cultivation ft. Dr. Tassa Saldi](https://www.dimepodcast.com/episodes/unveiling-the-4-million-problem-hop-latent-viroids-impact-on-cannabis-cultivation-ft-dr-tassa-saldi) — Dr. Tassa Saldi: This episode of The Dime features Dr. Tassa Saldi, Chief Scientific Officer at Tumi Genomics, explaining how hop latent viroid — a silent, genome-only pathogen — has quietly spread into roughly 80%…
  Markdown: https://www.dimepodcast.com/episodes/unveiling-the-4-million-problem-hop-latent-viroids-impact-on-cannabis-cultivation-ft-dr-tassa-saldi.md
- [Paul F. Austin on Exploring Psychedelics: Creativity, Hidden Benefits, Microdosing, and Retreats](https://www.dimepodcast.com/episodes/paul-f-austin-on-exploring-psychedelics-creativity-hidden-benefits-microdosing-and-retreats) — Paul F. Austin: This episode of The Dime features Paul F. Austin, founder of Third Wave and Synthesis, discussing the intersection of psychedelics, creativity, and leadership, including why many high-profile CEOs…
  Markdown: https://www.dimepodcast.com/episodes/paul-f-austin-on-exploring-psychedelics-creativity-hidden-benefits-microdosing-and-retreats.md
- [House of Puff Evolves: Introducing The Spritz](https://www.dimepodcast.com/episodes/house-of-puff-evolves-introducing-the-spritz) — Guest: This episode of The Dime features Kristina Adduci and Holly Hager, co-founders of House of Puff, discussing how their friendship and shared (initially hidden) cannabis use led them to build a brand…
  Markdown: https://www.dimepodcast.com/episodes/house-of-puff-evolves-introducing-the-spritz.md
- [Emergency Update: Shane Pennington Breaks Down Cannabis Rescheduling](https://www.dimepodcast.com/episodes/emergency-update-shane-pennington-breaks-down-cannabis-rescheduling) — Shane Pennington: This episode of The Dime features attorney Shane Pennington, partner at Porter Wright, breaking down the federal cannabis rescheduling process in granular detail — from HHS's recommendation and DEA's…
  Markdown: https://www.dimepodcast.com/episodes/emergency-update-shane-pennington-breaks-down-cannabis-rescheduling.md
- [Are Drugs Bad, The Future Cannabinoids as a Medicine 3.0 ft. Dr. Matthew Moore](https://www.dimepodcast.com/episodes/are-drugs-bad-the-future-cannabinoids-as-a-medicine-30-ft-dr-matthew-moore) — Dr. Matthew Moore: In his record third appearance on The Dime, Dr. Matthew Moore joins hosts Bryan Fields and Kellen Finney for a wide-ranging conversation spanning the safety and misuse of psychedelics (sparked by the…
  Markdown: https://www.dimepodcast.com/episodes/are-drugs-bad-the-future-cannabinoids-as-a-medicine-30-ft-dr-matthew-moore.md
- [Warren Bobrow: Bestselling Author & Cocktail Whisperer Reveals the Secret Ingredient for Crafting Cannabis Beverages](https://www.dimepodcast.com/episodes/warren-bobrow-bestselling-author-cocktail-whisperer-reveals-the-secret-ingredient-for-crafting-cannabis-beverages) — Warren Bobrow: In this episode of The Dime, bestselling author and 'Cocktail Whisperer' Warren Bobrow joins hosts Bryan Fields and Kellen Finney to trace his path from culinary school and years as an international…
  Markdown: https://www.dimepodcast.com/episodes/warren-bobrow-bestselling-author-cocktail-whisperer-reveals-the-secret-ingredient-for-crafting-cannabis-beverages.md
- [Dr. Matthew Johnson: The World's Most Published Scientist on the Human Effects of Psychedelics](https://www.dimepodcast.com/episodes/dr-matthew-johnson-the-worlds-most-published-scientist-on-the-human-effects-of-psychedelics) — Dr. Matthew Johnson: This episode of The Dime features Dr. Matthew Johnson, a Johns Hopkins professor and one of the most published scientists studying the human effects of psychedelics, discussing his 20-year research…
  Markdown: https://www.dimepodcast.com/episodes/dr-matthew-johnson-the-worlds-most-published-scientist-on-the-human-effects-of-psychedelics.md
- [Peter Barsoom: How 1906's has crafted Microdosing Cannabinoids with Targeted Effects](https://www.dimepodcast.com/episodes/peter-barsoom-how-1906s-has-crafted-microdosing-cannabinoids-with-targeted-effects) — Peter Barsoom: This episode of The Dime features Peter Barsoom, CEO and co-founder of 1906, discussing how he left a 20-year Wall Street career to build a cannabis edibles company focused on fast-acting, low-dose,…
  Markdown: https://www.dimepodcast.com/episodes/peter-barsoom-how-1906s-has-crafted-microdosing-cannabinoids-with-targeted-effects.md
- [Boosting Revenue with Crop Cycle Monitoring: How Sensors Increase Your Yield and Bottom Line](https://www.dimepodcast.com/episodes/boosting-revenue-with-crop-cycle-monitoring-how-sensors-increase-your-yield-and-bottom-line) — Scott Campbell: This episode of The Dime features Scott Campbell, president of METER Group and the team behind AROYA, a crop cycle monitoring platform built on decades of substrate-sensor research originally…
  Markdown: https://www.dimepodcast.com/episodes/boosting-revenue-with-crop-cycle-monitoring-how-sensors-increase-your-yield-and-bottom-line.md
- [Switching Spirits for Strains: Cannabis a Substitute for Alcohol ft Dr. Amanda Reiman](https://www.dimepodcast.com/episodes/switching-spirits-for-strains-cannabis-a-substitute-for-alcohol-ft-dr-amanda-reiman) — Dr. Amanda Reiman: This episode of The Dime features Dr. Amanda Reiman, Chief Knowledge Officer at New Frontier Data and founder of My Personal Plants, discussing how cannabis functions as a substitute for alcohol,…
  Markdown: https://www.dimepodcast.com/episodes/switching-spirits-for-strains-cannabis-a-substitute-for-alcohol-ft-dr-amanda-reiman.md
- [Matt Zorn: The Attorney Who Sued The DEA and Won](https://www.dimepodcast.com/episodes/matt-zorn-the-attorney-who-sued-the-dea-and-won) — Matt Zorn: In this episode of Dime, hosts Bryan Fields and Kellen Finney talk with attorney Matt Zorn of Yetter Coleman about his string of landmark lawsuits against the DEA on behalf of researcher Dr. Sue…
  Markdown: https://www.dimepodcast.com/episodes/matt-zorn-the-attorney-who-sued-the-dea-and-won.md

---

Markdown variant of any episode, guest, newsletter, answer or topic page on this site: add .md to its URL.
Site index: https://www.dimepodcast.com/llms.txt. Complete catalogue: https://www.dimepodcast.com/llms-full.txt
